# A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

> **NCT02598934** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 308 (actual)

## Conditions studied

- Post Menopausal Osteoporosis

## Interventions

- **DRUG:** Ibandronate

## Key facts

- **NCT ID:** NCT02598934
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 308 (ACTUAL)
- **Last updated:** 2016-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598934, "A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02598934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*